PremiumCompany AnnouncementsMAIA Biotechnology Showcases THIO-101 Trial at ELCC 2025 MAIA Biotechnology publishes preclinical data for telomere-targeting THIO dimer MAIA Biotechnology receives USAN Council approval for ‘Ateganosine’ name PremiumThe FlyMaia Biotechnology Inc trading halted, news pending Biotech Alert: Searches spiking for these stocks today MAIA Biotechnology Updates Executive Compensation Packages PremiumThe FlyMAIA Biotechnology granted FDA rare pediatric disease designation for THIO MAIA Biotechnology to sell 507,364 shares at $1.872 in private placement MAIA Biotechnology, Regeneron expand clinical supply agreement